Clinical Research Conference 2022, Dallas, TX (June 16, 2022)

Thank you to everyone who attended our hybrid Clinical Research Conference in Dallas, Texas! We brought together treating physicians, care teams, researchers, and families to share the latest updates on SLC13A5 Epilepsy (Citrate Transporter Disorder).

Research topics included:

  • Clinical Overview of SLC13A5 Epilepsy
  • Current treatments for SLC13A5 Epilepsy
  • Movement disorders in SLC13A5 Epilepsy and treatment options
  • Biomarkers and outcome measures for SLC13A5 Epilepsy
  • Learning from the lab: preclinical toolkit overview
  • Gene therapy for SLC13A5 Epilepsy and discussion on gene therapies for other disorders
  • Clinical trial overview

During the conference there was a live pediatric neurological exam, a discussion about SLC13A5 Epilepsy from a family perspective, and a chance for researchers and clinicians to meet children with SLC13A5 Epilepsy.

Please email tanya@tessfoundation.org or kim@tessfoundation.org with any questions.